InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
1
T+90 hit rate
36%
T+90 mean return
+5.9%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by MIGAUSKY GEORGE V, Directeur. Officer active across 3 companies, notably Immunovant, Inc.. Cumulatively, 26 filings have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €241k. History available since 20 August 2021. The latest transaction was disclosed on 1 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations26 total
16,188 shares0Common StockSEC:0001764013-25-000041:0
4,790 shares0Common StockSEC:0001562180-24-004655:0
11,255 shares0Common StockSEC:0001764013-24-000063:0
4,200 shares@ US$38.7962.0% of flowCommon StockSEC:0001764013-23-000153:0
3,486 shares0Common StockSEC:0001562180-23-004892:0
12,523 shares0Common StockSEC:0001764013-23-000044:0
21,059 shares0Common StockSEC:0001764013-22-000093:0
3,010 shares0Common StockSEC:0001562180-22-004879:0
21,726 shares0Common StockSEC:0001764013-22-000019:0
21,726 shares0Common StockSEC:0001764013-22-000019
7,000 shares@ US$7.650.0008% mcap50.0% of flowCommon StockSEC:0001764013-21-000090:0
Canonical exit: 18 Nov 2021 (T+90)
7,000 shares@ US$7.6519.0% of flowCommon StockSEC:0001764013-21-000090
Canonical exit: 18 Nov 2021 (T+90)
751,975 sharesCommon StockSEC:0000908662-16-000437:0
15,000 sharesCommon StockSEC:0000908662-16-000437:1
42,734 sharesCommon StockSEC:0000908662-16-000404:0
87,729 sharesCommon StockSEC:0000908662-16-000404:1
50,007 sharesCommon StockSEC:0000908662-16-000404:2
91,042 sharesCommon StockSEC:0000908662-16-000404:3
39,999 sharesCommon StockSEC:0000908662-16-000404:4
15,000 sharesCommon StockSEC:0000908662-16-000404:5
62,500 sharesCommon StockSEC:0000908662-16-000404:6
142,239 sharesCommon StockSEC:0000908662-16-000390:0
12,266 sharesCommon StockSEC:0000908662-16-000381:0
37,271 sharesCommon StockSEC:0000908662-16-000381:1
47,761 sharesCommon StockSEC:0000908662-16-000381:2
25 of 26 declarations
About MIGAUSKY GEORGE V
George V. Migausky is a Director at Immunovant, Inc. and REGENXBIO Inc. In this role, he provides his expertise to the board of directors to guide the strategy of the companies. George is involved in evaluating performance and initiatives that support growth objectives. His experience in the biopharmaceutical sector is valuable for both companies.
